INVESTOR RELATIONS

Stock price
NYSEVAR
Press Releases
Feb 11, 2020

Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethosā„¢ therapy, an Adaptive Intelligenceā„¢ solution. Ethos therapy is an artificial intelligence (AI)-driven...

Jan 29, 2020

Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at...

Jan 29, 2020

First Quarter 2020 Summary Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in...

Jan 20, 2020

Varian (NYSE: VAR) today announced it has appointed Dr. Ricky Sharma, to vice president of Clinical Affairs. In this role he will be leading medical research, translational science and clinical...

View all press releases

Upcoming Events
No events to display

View all events

Past Events
Thursday, February 13, 2020
4:30pm PST

Participant Dial-In: 877-407-9708 / 201-689-8259

Wednesday, January 29, 2020
1:30pm PST

Teleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261. Replay: Access from within the U.S. by dialing 1-877-660-6853 and from...

Monday, January 13, 2020
10:30am PST
Friday, November 15, 2019
8:00am EST

Registration is required. Please email Katie Glenn at katie.glenn@varian.com by November 8, 2019.

View more events

Quarterly Results
Contact Info

Anshul Maheshwari

VP, Treasurer and Investor Relations
1 650 424 6081
Anshul.Maheshwari@varian.com

 

Contact information

Varian Corporate Headquarters
3100 Hansen Way
Palo Alto, CA 94304-1038

1 (650)424-5631

investors@varian.com

Investor alerts

Stay up to date on the latest investor information.